Skip to main content
. Author manuscript; available in PMC: 2023 Jun 19.
Published in final edited form as: Psychooncology. 2022 Jul 6;31(9):1536–1544. doi: 10.1002/pon.5986

TABLE 1.

Sample characteristics (N = 88)

Mean (SD) Number (%)
Age 58.60 (14.63)
% Female 42 (47.7%)
BMI 30.91 (8.28) -
Physical comorbidities 1.41 (2.19) -
Race
 White - 79 (89.8%)
 Black - 6 (6.8%)
 Native American - 3 (3.4%)
Cancer stage
 I - 23 (26.1%)
 II - 16 (18.1%)
 III - 20 (22.7%)
 IV - 26 (29.5%)
No longer menstruating - 26 (61.9%)
Depression 15.96 (10.41) -
Anxiety 11.75 (9.42) -
Pain 2.63 (2.71) -
Fatigue 15.20 (20.80) -
CRP 8.23 (16.52) -

Note: CRP data represents non-log transformed values.

Abbreviations: Anxiety, Anxiety symptoms assessed via the Beck Anxiety Inventory; BMI, body mass index; CRP, C-reactive protein; Depression, Depressive symptoms as measured by the Center for Epidemiological Studies Depression Scale; SD, standard deviation.